AURKA and transitional cell carcinoma: We initially tested the AURKA FISH probe on paired samples of voided urine and bladder tumor tissue from a cohort of 40 patients with bladder cancer that contained 14 patients with low grade transitional cell carcinomas (LGTCC) and 26 patients with high grade transitional cell carcinomas (HGTCC) (Fig. 5a,b).